Substantial progress in the treatment of atherosclerotic complications – in particular in secondary prevention – has led to a significant reduction of recurrent cardiovascular events. This has been through the use of pharmacological strategies including lipid-lowering drugs such as statins, beta-blockers, angiotensin-converting ensyme inhibitors and angiotensin receptor blockers, along with the introduction of early percutaneous coronary intervention in acute coronary syndrome with consecutive application of dual antiplatelet therapy.
Atherosclerosis
Atherosclerosis
About
Media
Articles
Bilateral Lower Limb Disabling Claudication in a Young Man: A Case of Mönckeberg’s Arteriosclerosis
Published:
26 February 2019
Citation:
Vascular & Endovascular Review 2019;2(1):48–52.
- Views:
1
- Downloads:
0
The Role of Atherectomy in Peripheral Artery Disease: Current Evidence and Future Perspectives
Published:
22 January 2019
Citation:
Vascular & Endovascular Review 2019:2(1):12–8.
- Views:
2
- Downloads:
0
Endovascular Treatment of Common Femoral Artery Atherosclerotic Disease
Published:
31 August 2018
Citation:
Vascular & Endovascular Review 2018;1(1):12–6.
- Views:
1
- Downloads:
0
Hypertension In Chronic Kidney Disease – Role of Arterial Calcification and Impact on Treatment
Published:
19 November 2014
Citation:
European Cardiology Review 2014;9(2):115–20
- Views:
0
- Downloads:
0